Abstract
Background: Concurrent use of cannabis and alcohol is frequent. According different studies, the prevalence is among 20-34% depending on different samples studied.
Objective: In contrast with the wide evidence available about neuropsychiatric effects associated to the use of cannabis or alcohol separately, there are few studies of the neuropsychiatric effects of their combination. Our aim was to review the literature regarding this topic. Conclusion: We performed a search in MEDLINE and from 114 potentially eligible studies, 27 were selected. Most of them studied the relation between cannabis and alcohol, and with them combined to other substances of abuse, but only a few considered their concurrent effect among mental disorders (ADHD, bipolar disorder) and neuropsychological performance. More research in the neuropsychiatric effects of the concomitant use of cannabis and alcohol is needed.Keywords: Cannabis, Marijuana, alcohol, ethanol, concurrent use, neuropsychiatric effects, mental disorders, dual diagnosis.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Concurrent Use of Cannabis and Alcohol: Neuropsychiatric Effect Consequences
Volume: 16 Issue: 5
Author(s): Anna Romaguera, Marta Torrens*, Esther Papaseit, Ana Lucia Arellano and Magi Farré
Affiliation:
- Addiction Program, Institut de Neuropsiquiatria i Addiccions (INAD-IMIM-PSMAR) and Department of Psychiatry, Universitat Autònoma de Barcelona, Passeig Maritim 25, 08003 Barcelona,Spain
Keywords: Cannabis, Marijuana, alcohol, ethanol, concurrent use, neuropsychiatric effects, mental disorders, dual diagnosis.
Abstract: Background: Concurrent use of cannabis and alcohol is frequent. According different studies, the prevalence is among 20-34% depending on different samples studied.
Objective: In contrast with the wide evidence available about neuropsychiatric effects associated to the use of cannabis or alcohol separately, there are few studies of the neuropsychiatric effects of their combination. Our aim was to review the literature regarding this topic. Conclusion: We performed a search in MEDLINE and from 114 potentially eligible studies, 27 were selected. Most of them studied the relation between cannabis and alcohol, and with them combined to other substances of abuse, but only a few considered their concurrent effect among mental disorders (ADHD, bipolar disorder) and neuropsychological performance. More research in the neuropsychiatric effects of the concomitant use of cannabis and alcohol is needed.Export Options
About this article
Cite this article as:
Romaguera Anna , Torrens Marta *, Papaseit Esther , Arellano Lucia Ana and Farré Magi , Concurrent Use of Cannabis and Alcohol: Neuropsychiatric Effect Consequences, CNS & Neurological Disorders - Drug Targets 2017; 16 (5) . https://dx.doi.org/10.2174/1871527316666170419161839
DOI https://dx.doi.org/10.2174/1871527316666170419161839 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Psychoneuroimmunology - Psyche and Autoimmunity
Current Pharmaceutical Design The Effects of Aging on Haptic Working Memory During Length Discrimination
Neuroscience and Biomedical Engineering (Discontinued) Nanoneuromedicines for Neurodegenerative Diseases
Nanoscience & Nanotechnology-Asia Protective Effects of Incretin Against Age-Related Diseases
Current Drug Delivery Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
Current Pharmaceutical Design Histamine in Immune Regulation: Possible Roles in Autoimmune Demyelinating Disease of the Central Nervous System
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia
CNS & Neurological Disorders - Drug Targets ADAM Proteases: Protective Role in Alzheimers and Prion Diseases ?
Current Alzheimer Research One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Current Neuropharmacology Cholinergic Receptor System as a Target for Treating Alcohol Abuse and Dependence
Recent Patents on CNS Drug Discovery (Discontinued) Educating Scientists in Translational and Entrepreneurial Medicine: Unmet Needs and Challenges
Technology Transfer and Entrepreneurship (Discontinued) Meet Our Editorial Board Member
Current Alzheimer Research Pathological Reorganization of NMDA Receptors Subunits and Postsynaptic Protein PSD-95 Distribution in Alzheimer’s Disease
Current Alzheimer Research Anti-Copper Therapies in Alzheimers Disease: New Concepts
Recent Patents on CNS Drug Discovery (Discontinued) Immunophenotype of Vitamin D Receptor Polymorphism Associated to Risk of HIV-1 Infection and Rate of Disease Progression
Current HIV Research Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia
Current Psychiatry Reviews Common Neural Mechanisms of Palatable Food Intake and Drug Abuse: Knowledge Obtained with Animal Models
Current Pharmaceutical Design The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases
Reviews on Recent Clinical Trials Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Pharmacological Treatments for Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)